One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

With a simple skin biopsy, researchers can learn about neurological conditions that may be associated with long COVID.

The covid-19 pandemic changed our lives, and the world, in many ways - and now we are starting to understand its wider neurological effects ...

Long COVID continues to affect millions, with symptoms that mirror those of myalgic encephalomyelitis/chronic fatigue ...

Long COVID patients with abnormal cardiopulmonary PET/MR findings may be more likely to develop heart and lung diseases ...

In today's Morning Rounds newsletter: a failed long Covid drug may get another shot, the benefits of even a little activity ...

Today we advance these efforts by issuing a “call to action” for progress on Long COVID research as part of a National Research Action Plan on Long COVID released today. We are also releasing ...

A pre-pandemic common cold coronavirus infection may help set the stage for long COVID, according to Boston researchers who have been looking to explain why some patients end up facing the long-las… ...

Advocates say the federal government is no longer viewing long COVID with the urgency it deserves. Private donors are now funding research bringing an unprecedented level of collaboration.

Advocates say the federal government no longer views long COVID with urgency. Private donors are funding research, bringing an unprecedented level of collaboration. (Story aired on ATC on 2/6/24.) ...

The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.